The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Purpose of Review: The objective of this review is to critically assess the contributing role of the gut microbiota in human obesity and type 2 diabetes (T2D). Recent Findings: Experiments in animal and human studies have produced growing evidence for the causality of the gut microbiome in developing obesity and T2D. The introduction of high-throughput sequencing technologies has provided novel insight into the interpersonal differences in microbiome composition and function. Summary: The intestinal microbiota is known to be associated with metabolic syndrome and related comorbidities. Associated diseases including obesity, T2D, and fatty liver disease (NAFLD/NASH) all seem to be linked to altered microbial composition; however, causality has not been proven yet. Elucidating the potential causal and personalized role of the human gut microbiota in obesity and T2D is highly prioritized.
Original languageEnglish
Article number55
JournalCurrent Diabetes Reports
Volume18
Issue number8
DOIs
Publication statusPublished - 2018

Cite this